Eikonizo Therapeutics Alternatives & Competitors

12 companies similar to Eikonizo Therapeutics — Envisioning an end to neurodegenerative diseases.

Spinogenix, Inc.

Developing a new class of therapeutics for neurodegenerative and psychiatric diseases

4 $8.36M

Los Angeles, United State...

Biotechnology Health Care +1

Cantabio Pharmaceuticals, Inc.

Cantabio aim to slow, stop and even prevent the onset & progression of neurodegenerative d...

13 Grant

Sunnyvale, United States

Biotechnology Pharmaceutical

Cognition Therapeutics, Inc.

Advancing Accessible Solutions for Complex Neurodegenerative Diseases

29 IPO $161.89M

United States

Biotechnology Health Care +3

Vigil Neuroscience

Harnessing the power of microglia to transform treatments for neurodegenerative diseases

76 Acquired $650.00M

Watertown, United States

Biotechnology Health Care

Rival Readout

Competing with Eikonizo Therapeutics? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Rubedo Life Sciences

Medicines to keep you biologically young by targeting the pathological cells that drive ch...

32 Series A $53.45M

Sunnyvale, United States

Biotechnology Health Care +1

Libra Therapeutics

Restoring Cellular Balance: Developing novel therapeutics for neurodegenerative disease

4 Series A $29.00M

San Diego, United States

Biotechnology Health Care

Vertero Therapeutics, Inc.

Pioneering science beyond the brain to treat neurodegenerative diseases at their source

12 Series C $110.90M

Woburn, United States

Biopharma Biotechnology +1

Ophidion

Advancing brain-targeted therapies with precision and innovation for neurodegenerative and...

Convertible Note $1.70M

Biotechnology Health Care +1

Gain Therapeutics

Unfolding the next generation of allosteric small molecule therapies to meet patient needs...

26 IPO $83.04M

Bethesda, United States

Biotechnology Pharmaceutical

Kineta (Reverse Merger With Yumanity Therapeutics)

Pioneering new horizons in neurodegenerative disease treatment by addressing protein misfo...

Venture round $137.36M

Biotechnology Health Care +1

Handl Therapeutics

Handl Therapeutics develops gene therapies for complex neurodegenerative diseases through...

Grant $3.00M

Leuven, Belgium

Biotechnology Health Care +1

Psy Therapeutics

Creating new futures in central nervous system (CNS) treatment and care.

11 Seed $3.97M

Boston, United States

Biotechnology Health Care +1

Frequently Asked Questions

Companies similar to Eikonizo Therapeutics include Spinogenix, Inc., Cantabio Pharmaceuticals, Inc., Cognition Therapeutics, Inc., Vigil Neuroscience, Rubedo Life Sciences. They work in Biotechnology and Health Care.

Bounce Watch lists 12 companies that share Eikonizo Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Eikonizo Therapeutics, founded in 2017, is a biotechnology company based in the United States that is committed to envisioning an end to neurodegenerative diseases. The company's mission is to develop life-changing therapies by creating brain-penetrant small molecules and deploying in vivo target engagement techniques...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Eikonizo Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Eikonizo Therapeutics Profile Spinogenix, Inc. Alternatives Cantabio Pharmaceuticals, Inc. Alternatives Cognition Therapeutics, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Eikonizo Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 26 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.